FDA Inspection 1304594 - Staska Pharmaceuticals, Inc. - February 20, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Staska Pharmaceuticals, Inc., with an inspection on February 20, 2026, issued by the Kansas City District Office, covering human drugs.

Company: Staska Pharmaceuticals, Inc.
Inspection Date: February 20, 2026
Product Type: Human Drugs
Office: Kansas City District Office

Open in Dashboard

ID · 98351a0f-62de-4229-a79d-6603afa06f3c

Violation Codes3

21 CFR 211.160(b)21 CFR 211.19221 CFR 211.42(c)(10)(iv)

Full citation text and observation details available on the Dashboard.